HomeCompareFSBN vs ABBV

FSBN vs ABBV: Dividend Comparison 2026

FSBN yields 158.34% · ABBV yields 3.06%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FSBN wins by $32.90M in total portfolio value
10 years
FSBN
FSBN
● Live price
158.34%
Share price
$1.26
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$33.01M
Annual income
$14,719,664.49
Full FSBN calculator →
ABBV
AbbVie Inc.
● Live price
3.06%
Share price
$217.44
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.3K
Annual income
$24,771.77
Full ABBV calculator →

Portfolio growth — FSBN vs ABBV

📍 FSBN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFSBNABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FSBN + ABBV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FSBN pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FSBN
Annual income on $10K today (after 15% tax)
$13,458.95/yr
After 10yr DRIP, annual income (after tax)
$12,511,714.82/yr
ABBV
Annual income on $10K today (after 15% tax)
$259.96/yr
After 10yr DRIP, annual income (after tax)
$21,056.00/yr
At 15% tax rate, FSBN beats the other by $12,490,658.81/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FSBN + ABBV for your $10,000?

FSBN: 50%ABBV: 50%
100% ABBV50/50100% FSBN
Portfolio after 10yr
$16.55M
Annual income
$7,372,218.12/yr
Blended yield
44.53%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

FSBN
No analyst data
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+17.8% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FSBN buys
0
ABBV buys
0
No recent congressional trades found for FSBN or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFSBNABBV
Forward yield158.34%3.06%
Annual dividend / share$2.00$6.65
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.6%
Portfolio after 10y$33.01M$102.3K
Annual income after 10y$14,719,664.49$24,771.77
Total dividends collected$30.66M$61.0K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FSBN vs ABBV ($10,000, DRIP)

YearFSBN PortfolioFSBN Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$26,534$15,834.06$11,550$430.00+$15.0KFSBN
2$67,657$39,265.59$13,472$627.96+$54.2KFSBN
3$165,963$93,570.23$15,906$926.08+$150.1KFSBN
4$392,093$214,512.63$19,071$1,382.55+$373.0KFSBN
5$893,178$473,638.06$23,302$2,095.81+$869.9KFSBN
6$1,964,050$1,008,350.10$29,150$3,237.93+$1.93MFSBN
7$4,173,784$2,072,250.42$37,536$5,121.41+$4.14MFSBN
8$8,581,575$4,115,625.32$50,079$8,338.38+$8.53MFSBN
9$17,090,692$7,908,407.21$69,753$14,065.80+$17.02MFSBN
10$33,006,705$14,719,664.49$102,337$24,771.77+$32.90MFSBN

FSBN vs ABBV: Complete Analysis 2026

FSBNStock

FrankSpeech Network, Inc. operates a broadcast platform. The company operates FrankSpeech, a technology platform that hosts content and content creators, as well as social media space for upholding free speech for everyone. It also operates Banana Box Wholesale Grocery, a wholesale grocery distributor that offers dry goods and shelf stable groceries, frozen-refrigerated food products, and freeze dried foods servicing grocery retailers; and Leading Edge Radio Network. The company is headquartered in Greenwood Village, Colorado.

Full FSBN Calculator →

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →
📬

Get this FSBN vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FSBN vs SCHDFSBN vs JEPIFSBN vs OFSBN vs KOFSBN vs MAINFSBN vs JNJFSBN vs MRKFSBN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.